LOPE vs VRTX · P/E 23, rev $572.8M vs P/E 30, rev $3.33B
Grand Canyon Education Inc (LOPE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Grand Canyon Education Inc (LOPE) is a education & training services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LOPE revenue for 2026-06-30 was $572.8M. Net income was $121.2M. Revenue was up 85.5% from 2026-03-31 to 2026-06-30. LOPE currently screens at market cap $5.20B and trailing P/E 23.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LOPE currently screens at market cap $5.20B and trailing P/E 23.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LOPE and VRTX stock pages for the full models.
Not investment advice.